MONTEMURRO, Pasqualina
 Distribuzione geografica
Continente #
NA - Nord America 1943
EU - Europa 528
AS - Asia 172
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2649
Nazione #
US - Stati Uniti d'America 1941
CN - Cina 150
SE - Svezia 147
DE - Germania 90
UA - Ucraina 81
IT - Italia 74
FI - Finlandia 46
GB - Regno Unito 34
FR - Francia 33
BE - Belgio 14
IR - Iran 10
IN - India 7
RU - Federazione Russa 6
VN - Vietnam 4
EU - Europa 3
CA - Canada 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
IE - Irlanda 1
KR - Corea 1
PL - Polonia 1
TN - Tunisia 1
Totale 2649
Città #
Fairfield 317
Woodbridge 272
Chandler 221
Jacksonville 187
Seattle 131
Nyköping 118
Ann Arbor 112
Ashburn 107
Houston 106
Cambridge 98
Wilmington 95
Beijing 47
Lawrence 45
Roxbury 45
Nanjing 42
Des Moines 27
Princeton 26
Boardman 24
Inglewood 22
Brooklyn 19
Brussels 14
Hebei 14
Bari 13
San Diego 13
Shenyang 12
Nanchang 11
Strasbourg 9
Ardabil 7
San Mateo 7
Augusta 6
Changsha 6
Leawood 6
Tianjin 6
Jiaxing 5
Redwood City 5
Dong Ket 4
Foggia 4
Norwalk 4
Paris 4
Auburn Hills 3
Helsinki 3
Rome 3
Trieste 3
Bangalore 2
Grafing 2
Jinan 2
Milan 2
Naples 2
Ningbo 2
Padova 2
Sabz 2
San Francisco 2
Sorrento 2
Trento 2
Acquaviva Delle Fonti 1
Bologna 1
Bremen 1
Brindisi 1
Canberra 1
Catania 1
Chioggia 1
Dearborn 1
Empoli 1
Forlì 1
Formigine 1
Fuzhou 1
Genova 1
Guangzhou 1
Haikou 1
Indiana 1
Jesi 1
London 1
Los Angeles 1
Markham 1
Molinella 1
Monmouth Junction 1
Mumbai 1
Putignano 1
Rimini 1
Seoul 1
São Paulo 1
Toronto 1
Verona 1
Yambol 1
Totale 2275
Nome #
Increase in interleukin-8 production from circulating neutrophils upon antibiotic therapy in cystic fibrosis patients 136
Antibiotic therapy affects functional behaviour in cystic fibrosis blood mononuclear cells 106
Procoagulant activity of human alveolar macrophages: different expression in patients with lung cancer 88
G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis 88
Insulin-like growth factor-6 (IGFBP-6) stimulates neutrophil oxidative burst, degranulation and chemotaxis. 82
CFTR-dependent chloride efflux in cystic fibrosis mononuclear cells is increased by ivacaftor therapy 82
null 80
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 74
ENHANCED ENDOTHELIAL TISSUE FACTOR BUT NORMAL THROMBOMODULIN IN ENDOTOXIN-TREATED RABBITS. 73
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 72
Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma 71
Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet 70
Streptococcus pneumoniae modulates the respiratory burst response in human neutrophils 69
URINARY PROCOAGULANT AND FIBRINOLYTIC-ACTIVITY IN HUMAN GLOMERULONEPHRITIS - RELATIONSHIP WITH RENAL-FUNCTION 68
Aggregation of human peripheral blood mononuclear cells by calcium ionophore A23187. Comparison with the aggregation of platelets and defective response in Glanzmann's thrombasthenia 66
Blood and tissue fibrinolytic profile in patients with colorectal cancer 66
null 64
Problems in idetifying microbial-derived neutrophil activators, focusing on Helicobacter pylori 63
Shock, sindrome da insufficienza multiorgano e ustioni nell'adulto. 60
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors 60
Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis 58
The neutrophil-activating protein (HP-NAP)of Helicobacter pylori is a potent stimulant of mast cells 57
Cellular coagulation-fibrinolysis balance and atherosclerosis 56
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits 54
Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leukocytes 53
The neutrophil-activating protein of Helicobacter pylori 52
Cellular and plasmatic anomalies of the coagulation system and fibrinolysis in children with lymphomas and influence of cytostatic treatment 50
Inhibitory effect of retinoids on the generation of procoagulant activity by blood mononuclear phagocytes 49
Streptococcus pneumoniae induces mast cell degranulation 49
Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies 49
Unbalanced coagulation-fibrinolysis potential of blood mononuclear cells and reduced plasma fibrinolytic capacity in lymphoma patients 47
Alterazioni dell'equilibrio coagulativo-fibrinolitico dei monociti e della capacità fibrinolitica plasmatica dei linfomi 46
Nicotine effects on polymorphonuclear cell apoptosis and lipopolysaccharida-induced monocyte functions. A possible role in periodontal disease? 42
Helicobacter pylori neutrophil activating protein stimulates tissue factor and plasminogen inhibitor-2 production by human blood mononuclear cells 41
Urinary procoagulant anf fibrinolytic activity in human glomerulonephritis 39
Anomalie cellulari e plasmatiche della coagulazione e della fibrinolisi dei linfomi ed effetto della terapia 39
Evaluation of genome-wide expression profiles of blood neutrophils in cystic fibrosis patients before and after antibiotic therapy. 37
Evaluation of genome-wide expression profiles of blood neutrophils in Cystic Fibrosis patients before and after antibiotic therapy. 36
Emostasi cellulare 35
Studio di alcune funzioni leucocitarie (aggregazione ed attività procoagulante) nella malattia granulomatosa cronica 33
Treatment of cystic fibrosis patients homozygous for F508del with lumacaftor-ivacaftor (Orkambi®) restores defective CFTR channel function in circulating mononuclear cells 33
null 28
null 26
Involvment of leukocytes in hemostasis and thrombosis 25
Effect of Helicobacter pylori lipopolysaccaride and LPS derivates on the production of tissue factor and plasminogen activator inhibitor type 2 by human blood mononuclear cells 25
null 22
CPS genes of Streptococcus pneumoniae modulate inflammatory response of neutrophils 19
Studio di alcune funzioni leucocitarie (aggregazione ed attività procoagulante) nella malattia granulomatosa cronica 15
Le attività procoagulanti delle cellule ed il loro possibile significato fisiopatologico 14
null 12
Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy. 12
Reduction of tumor-associated fibrinolytic activity by antimetastatic dosages of two Ru(II)-DMSO complexes in mice bearing Lewis lung carcinoma 10
Role of neutrophils in cystic fibrosis lung 7
Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice 7
Meccanismo pro-infiammatorio di due fattori di virulenza prodotti da Helicobacter pylori 2
Totale 2717
Categoria #
all - tutte 5236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018167 0000 00 0143 10266
2018/2019289 4180 633 52 4469189
2019/2020784 141472870 8242 7457 90309330
2020/2021499 43273915 6132 4339 40706129
2021/2022348 1744016 1618 1322 27176593
2022/2023477 86746263 8098 140 0000
Totale 2717